BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 18566017)

  • 1. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
    Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
    Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions.
    Hubert P; Caberg JH; Gilles C; Bousarghin L; Franzen-Detrooz E; Boniver J; Delvenne P
    J Pathol; 2005 Jul; 206(3):346-55. PubMed ID: 15852499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
    Jiang M; Milner J
    Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
    Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
    Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
    Jiang B; Xue M
    Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20.
    Caberg JH; Hubert P; Herman L; Herfs M; Roncarati P; Boniver J; Delvenne P
    Cancer Immunol Immunother; 2009 Jan; 58(1):39-47. PubMed ID: 18438663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.
    Bottley G; Watherston OG; Hiew YL; Norrild B; Cook GP; Blair GE
    Oncogene; 2008 Mar; 27(12):1794-9. PubMed ID: 17828295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki].
    Niu XY; Peng ZL; Wang H
    Ai Zheng; 2004 Nov; 23(11):1257-62. PubMed ID: 15522169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch1 can contribute to viral-induced transformation of primary human keratinocytes.
    Lathion S; Schaper J; Beard P; Raj K
    Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].
    Peralta-Zaragoza O; Bermúdez-Morales VH; Madrid-Marina V
    Rev Invest Clin; 2010; 62(1):63-80. PubMed ID: 20415061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
    Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
    Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
    Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
    Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
    Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
    Subbaramaiah K; Dannenberg AJ
    Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-regulating functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression.
    von Knebel Doeberitz M; Gissmann L; zur Hausen H
    Cancer Res; 1990 Jun; 50(12):3730-6. PubMed ID: 1692767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha.
    Boccardo E; Manzini Baldi CV; Carvalho AF; Rabachini T; Torres C; Barreta LA; Brentani H; Villa LL
    Carcinogenesis; 2010 Mar; 31(3):521-31. PubMed ID: 20042637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.